CALR and cancer: Taking into account that doxorubicin, that is, the cytotoxic payload of Doxil, induces immunogenic cell death, we sought to examine the immunogenic effects of Doxil on metastasis via quantification of the surface calreticulin (CRT) on dying cancer cells [45] (Figure 3D).